• via The Independent
Britain's Pharmaceutical Exodus: When Even Big Pharma Won't Take Your Money
How Bureaucratic Short-Sightedness is Driving Life Sciences Out of the UK
When the CEO of a $700 billion pharmaceutical giant publicly declares that the UK is "probably the worst country in Europe" for drug prices, it's a stark warning sign. Eli Lilly's Dave Ricks isn't just lamenting high taxes; he's signaling a broader institutional failure that's driving investment and innovation out of Britain. This analysis explores how bureaucratic short-termism and irrational pricing schemes are dismantling what was once a global leader in life sciences.